Kiadis announces presentation at the 2020 Society for Immunotherapy of Cancer Annual Meeting
Kiadis announces presentation at the 2020 Society for Immunotherapy of Cancer Annual Meeting Amsterdam, The Netherlands, October 26, 2020 – Kiadis Pharma N.V. (“Kiadis” or the “Company”) (Euronext Amsterdam and Brussels: KDS), a clinical-stage biopharmaceutical company developing innovative NK-cell-based medicines for the treatment of life-threatening diseases, today announces that a poster was accepted for presentation […]
Read More